FDA Logo links to FDA home pageU.S. Food and Drug AdministrationHHS Logo links to Department of Health and Human Services website

FDA Home Page | Search FDA Site | A-Z Index | Contact FDA [Skip navigation]
horizonal rule

PMA Final Decisions Rendered for February 2005

related information

Some of the documents on this section of the CDRH Website are available only in PDF format and may not be accessible to those with certain disabilities. If you cannot access the documents you are interested in, please use the accessibility link for assistance. Below are Premarket Approvals (PMA), Product Development Protocols (PDP), Supplement and Notice Decisions. This list is generated on a monthly basis.

A PDF document that contains the "Approval letter and Summary of Safety and Effectiveness" is being added to this listing for each PMA. The PMA number will appear as a link if this document is available. Information about the PDF Reader is available.

PMA Original Approvals

None for February 2005.

PMA Supplemental Approvals

P810002/S058
2/14/05
Real-Time

SJM Masters Series Aortic Valved Prosthesis with Vascutek Gelweave Valsalva Graft (Model VAVGJ-515)

St. Jude Medical, Inc.
St. Paul, MN
55117

Approval for an additional configuration of the aortic valved graft using the SJM Masters Series Aortic Valved Prosthesis with the Vascutek Gelweave Valsalva Graft. The device, as modified, will be marketed under the trade name SJM Masters Series Aortic Valved prosthesis with Vascutek Gelweave Valsalva Graft (model VAVGJ-515) and is indicated for the replacement of a malfunctioning native or prosthetic aortic heart valve and ascending aorta.

P810055/S071
2/4/05
Real-Time

CeeOn PMMA UV-Light Absorbing Posterior Chamber (IOLs)

Advanced Medical Optics
Santa Ana, CA
92799

Approval to modify the “Indications” statements for all legally marketed IOLs under the above referenced PMAs to reflect adults as opposed to adults older than 60 years of age.

P840002/S010
2/3/05
180-Day

TapCath and TapScope Disposable Transesophageal Probes

CardioCommand, Inc.
Tampa, FL
33607

Approval for a manufacturing site at CardioCommand, Inc., Tampa, Florida.

P860004/S065
2/22/05
Real-Time

SynchroMed II Infusion System

Medtronic, Neurological
Minneapolis, MN
55432

Approval for modifications to the 1) Protocol driver for the SynchroMed II application software, 2) SynchroMed II application software, and 3) final Functional Test (FFT) manufacturing software.

P860004/S066
2/14/05
180-Day

SynchroMed® Implantable Infusion System for the Intrathecal Administration of Prialt® (ziconotide)

Medtronic, Neurological
Minneapolis, MN
55432

Approval for the Intrathecal Administration of Prialt (ziconotide). The device, as modified, will be marketed under the trade name SynchroMed Implantable Infusion System and is indicated for the chronic intrathecal infusion of preservative-free ziconotide sterile solution for the management of severe, chronic pain.

P860008/S017
2/3/05
180-Day

TapCath and TapScope Disposable Transesophageal Probes

CardioCommand, Inc.
Tampa, FL
33607

Approval for a manufacturing site at CardioCommand, Inc., Tampa, Florida.

P860019/S202
2/15/05
Special

PTCA Balloon Catheters, Express2™ Coronary Stent System and Taxus Express2™

Boston Scientific Corporation
Maple Grove, MN
55311

Approval to add a specification for acceptable pyrogen level to the hypotube component.

P880070/S011
2/4/05
Real-Time

CeeOn Heparin Surface Modified UV-Light Absorbing Anterior Chamber (IOLs)

Advanced Medical Optics
Santa Ana, CA
92799

Approval to modify the “Indications” statements for all legally marketed IOLs under the above referenced PMAs to reflect adults as opposed to adults older than 60 years of age.

P880081/S030
2/4/05
Real-Time

UV-Absorbing Silicone Posterior Chamber Intraocular Lenses (IOLs)

Advanced Medical Optics
Santa Ana, CA
92799

Approval to modify the “Indications” statements for all legally marketed IOLs under the above referenced PMAs to reflect adults as opposed to adults older than 60 years of age.

P890003/S079
2/15/05
180-Day

CareLink Monitor Models 2490G, 2490H and 2490J

Medtronic, Inc.
Minneapolis, MN
55432

Approval for a manufacturing site located at Plexus Services Corporation, Bothell, Washington.

P890003/S080
2/18/05
Real-Time

Medtronic Model 2090 CareLink Programmer with Telemetry C

Medtronic, Inc.
Minneapolis, MN
55432

Approval for the addition of distance telemetry functionality to the currently approved programmer. The device, as modified, will be marketed under the trade name Medtronic Model 2090 CareLink Programmer with Telemetry C and is indicated for use in the interrogation and programming of implantable medical devices.

P890057/S017
2/25/05
180-Day

Model 3100B High Frequency Oscillatory Ventilator

Bird Products Corporation
Palm Springs, CA
92262

Approval for a manufacturing site located at Bird Products Corporation, Palm Springs, California.

P900056/S082
2/9/05
Real-Time

Rotablator Rotational Angioplasty System

Boston Scientific Corp.
Maple Grove, MN
55311

Approval for changes to the Directions for Use (DFU) manual for the Rotablator console unit. The changes include removal of the references to the console recorder connection, updates to the contact information and catalog numbers, and other minor clarifications.

P910077/S046
2/10/05
180-Day

Model 3120 ZOOM? Latitude™ Programmer/Recorder/Monitor, Model 3122 Antenna accessory, Model 3130 Accessory kit, and Software Application Models 2909, 2812, 2833, 2840, 2841, 2843, 2844, 2845, 2848, 2849, 2857, 2865, 2880, 2881, 2890, 2891, 2892

Guidant Corporation
St. Paul, MN
55112

Approval for the Model 3120 ZOOM Latitude Programming System. The Model 3120 PRM is intended to be used as a complete system to communicate with Guidant implantable pulse generators. The software in use controls all communication functions for the pulse generator. For detailed software application instructions, refer to the System Guide for the Guidant pulse generator being interrogated.

P920014/S024
2/2/05
180-Day
Thoratec® HeartMate® XVE and VE Left Ventricular Assist System (LVAS) Thoratec Corporation
Burlington, MA
01803
Approval for modifications to the existing System Monitor design, which is used with the HeartMate XVE and VE devices.
P920047/S026
2/28/05
Real-Time
Blazer II and Blazer II XP Cardiac Ablation Catheters Boston Scientific Corporation
San Jose, CA
95134
Approval for the Blazer II and Blazer II XP catheters with modified steering wire subassemblies.
P930016/S019
2/18/05
180-Day
STAR S4™ Excimer Laser and WaveScan WaveFront® Systems VISX, Inc.
Santa Clara, CA
95051
Approval for the addition of an iris identification and registration system and an ozone compensation system to the STAR S4 Excimer Laser and WaveScan WaveFront Systems. The device, as modified, will be marketed under the trade name STAR S4-IE Excimer Laser System.
P950014/S023
2/18/05
180-Day
Prostatron™ Urologix, Inc.
Minneapolis, MN
55447
Approval for modification of the Prostatron labeling regarding the treatment of patients 1) with implanted active devices (including pacemakers and defibrillators), 2) in urinary retention, and 3) with median prostatic lobes.
P950014/S024
2/23/05
Real-Time
Prostatron™ Urologix, Inc.
Minneapolis, MN
55447
Approval to change location balloon material from latex to silicone, to change the method of attaching the location balloon due to the new material, and to remove the current latex sensitivity caution and other references to latex in the labeling.
P960040/S049
2/18/05
Real-Time
Model 2812 Version 1.3 Guidant Corporation
St. Paul, MN
55112
Approval for the application software Model 2812 version 1.3.
P970003/S055
2/1/05
Real-Time
NeuroCybernetic Prosthesis (NCP) System Cyberonics, Inc.
Houston, TX
77058
Approval for the Model 250 Programming Software – Version 7.0 for use with Model 100 Versions B and C, Model 101 Versions 1 and 2, and Models 102 and 102R pulse generators.
P970008/S024
2/18/05
180-Day
Targis System Urologix, Inc.
Minneapolis, MN
55447
Approval for modification of the Prostatron labeling regarding the treatment of patients 1) with implanted active devices (including pacemakers and defibrillators), 2) in urinary retention, and 3) with median prostatic lobes.
P970008/S025
2/15/05
Real-Time
Urologix Targis™ System for the Treatment of BPH Urologix, Inc.
Minneapolis, MN
55447
Approval for the following changes to the device: 1) the change of the insertion tip and adhesive of the Cooled ThermoCath Microwave Delivery System (CTC MDS) to increase to the flexibility of the catheter; 2) the change of the insertion tip and adhesive of the Targis™ Microwave Delivery System to the same catheter type as the CTC MDS; and 3) the addition of Texin 950 UV stabilized tubing for the shaft of the CTC catheter.
D970012/S016
2/11/05
180-Day
AMS 700 Series Product Line Inflatable Penile Prostheses with InhibiZone™ Antibiotic Surface Treatment American Medical Systems, Inc.
Minnetonka, MN
55343
Approval for updating the labeling of the AMS 700 InhibiZone™ treated devices to reflect the amount of antibiotics found on these device, as modified, will be marketed under the trade name AMS 700 Series Product Line Inflatable Penile Prostheses with InhibiZone™ Antibiotic Surface Treatment.
P970015/S030
2/4/05
Real-Time
LT-CAGE™ Lumbar Tapered Fusion Device (Ti and PEEK) Medtronic Sofamor Danek
Memphis, TN
38132
Approval for the inclusion of additional fusion cage component designs. Specifically, these design changes involved the incorporation of a rounded profile to the closed end of the tapered cage components. The modified tapered cage components can only be implanted via an anterior open surgical approach.
P970018/S009
2/11/05
Real-Time
PrepStain™ System Tripath Imaging, Inc.
Durham, NC
27703
Approval for modification to the SurePath™ Slide preparation method which will be marketed under the trade name PrepStain™ System and is indicated for use as a liquid-based thin layer cell preparation process. The PreStain™ System produces SurePath™ slides that are intended as replacements for conventional gynecologic Pap smears. Surepath™ slides are intended for use in the screening and detection of cervical cancer, pre-cancerous lesions, atypical cells and all other cytologic categories as defined by The Bethesda System for Reporting Cervical/Vaginal Cytologic Diagnoses.
P970058/S020
2/17/05
180-Day
ImageChecker M5000, ImageChecker M5000 DM, ImageChecker M5000LX, ImageChecker M5000 M5000 DX Version 8.0 R2 Technology, Inc.
Sunnyvale, CA
94087
Approval for improvements in the CAD detection algorithm and the introduction of more choice in operating points for both analog and digital images.
P980040/S006
2/4/05
Real-Time
Sensar Soft Acrylic UV-Light Absorbing Posterior Chamber (IOLs) Advanced Medical Optics
Santa Ana, CA
92799
Approval to modify the “Indications” statements for all legally marketed IOLs under the above referenced PMAs to reflect adults as opposed to adults older than 60 years of age.
P990053/S011
2/25/05
135-Day
Oxifirst™ Fetal Oxygen Saturation Monitoring System Nellcor Puritan Bennett, Inc.
Pleasanton, CA
94588
Approval for the qualification of an additional supplier for the two light emitting diodes within the oximetry sensor.
P990080/S005
2/4/05
Real-Time
CeeOn Edge and Tecnis Foldable UV-Light Absorbing Posterior Chamber (IOLs) Advanced Medical Optics
Santa Ana, CA
92799
Approval to modify the “Indications” statements for all legally marketed IOLs under the above referenced PMAs to reflect adults as opposed to adults older than 60 years of age.
P000058/S015
2/4/05
Real-Time
InFUSE™ Bone Graft/LT-CAGE™ Lumbar Tapered Fusion Device Medtronic Sofamor Danek
Memphis, TN
38132
Approval for the inclusion of additional fusion cage component designs. Specifically, these design changes involved the incorporation of a rounded profile to the closed end of the tapered cage components. The modified tapered cage components can only be implanted via an anterior open surgical approach.
P010012/S031
2/9/05
180-Day
CONTAK RENEWAL 3 RF CRT-D Models H210/H215/H250/H255 and CONTAK
RENEWAL 3 RF HE CRT-D Models H217/H219/H257/H259 and CONSULT
Programmer Software Application, Model 2845 Version 4.6
Guidant Corporation
St. Paul, MN
55112
Approval for the addition of wandless telemetry to your currently market-approved CRT-D devices that will allow communication with the programmer at an increased distance. The device, as modified, will be marketed under the trade name CONTAK RENEWAL 3 RF and is indicated for the following: The CONTAK RENEWAL 3 RF CRT-D is indicated for patients with moderate to severe heart failure (NYHA III/IV) who remain symptomatic despite stable, optimal heart failure drug therapy, and have left ventricular dysfunction (EF = 35%) and QRS duration = 120 ms.
P010012/S041
2/11/05
Special
CONTAK RENEWAL 3, Models H170, H175, H177 and H179 Guidant Corporation
St. Paul MN
55112
Approval for labeling changes.
P010012/S042
2/2/05
Real-Time
CONTAK RENEWAL CRT-D Model H125 Guidant Corporation
St. Paul, MN
55112
Approval for header assembly changes to the device. The device, as modified, will be marketed under the trade name Contak Renewal CRT-D Model H135.
P010021/S005
2/11/04
Special
VITROS Immunodiagnostic Anti-HCV Reagent Pack and Calibrator Ortho-Clinical Diagnostics, Inc.
Rochester, NY
14626
Approval for modification of raw material specification.
P010025/S005
2/18/05
180-Day
Selenia Full Field Digital Mammography System Lorad
Danbury, CT
06810
Approval for addition of automatic exposure (AEC) system, and related changes in Operator’s Manual and QC test and QC manual under MQSA.
P010030/S006
2/15/05
Real-Time
LifeVest™ (WCD® 300) Device with Application Software Version 4.0 Lifecor, Inc.
Pittsburgh, PA
15231
Approval for minor changes in software, hardware and associated labeling.
P020009/S019
2/15/05
Special
Express,
Express2™ Coronary Stent System (Monorail and Over-the-Wire)
Boston Scientific Corporation
Maple Grove, MN
55311
Approval for labeling changes that strengthen the instructions regarding appropriate methods to be used when a physician experiences withdrawal resistance following stent deployment and balloon deflation.
P020009/S020
2/15/05
Special
PTCA Balloon Catheters, Express2 Coronary Stent System and Taxus Express2 Boston Scientific Corporation
Maple Grove, MN
55311
Approval to add a specification for acceptable pyrogen level to the hypotube component.
P020025/S010
2/28/05
Real-Time
Blazer II and Blazer II XP Cardiac Ablation Catheters Boston Scientific Corporation
San Jose, CA
95134
Approval for the Blazer II and Blazer II XP catheters with modified steering wire subassemblies.
P020050/S002
2/15/05
Real-Time
WaveLight ALLEGRETTO WAVE™ Excimer Laser System WaveLight Laser Technologie AG Approval for Notebook software changes to the new software version (NB-042201) that involve: 1) a change in the notation used to enter refraction; and 2) the software menu location at which users may select different values for flap thickness based on the type of microkeratome used to create corneal flaps.
P030008/S002
2/15/05
Real-Time
WaveLight ALLEGRETTO WAVE™ Excimer Laser System Wavelight Laser Technologie AG Approval for Notebook software changes to the new software version (NB-042201) that involve: 1) a change in the notation used to enter refraction; and 2) the software menu location at which users may select different values for flap thickness based on the type of microkeratome used to create corneal flaps.
P030025/S014
2/15/05
Special
TAXUS™ Express2™ Paclitaxel-Eluting Coronary Stent System (Monorail and Over-the-Wire) Boston Scientific Corporation
Maple Grove, MN
55311
Approval for labeling changes that strengthen the instructions regarding appropriate methods to be used when a physician experiences withdrawal resistance following stent deployment and balloon deflation.
P030025/S015
2/15/05
Special
PTCA Balloon Catheters, Express2™ Coronary Stent System and Taxus Express2™ Boston Scientific Corporation
Maple Grove, MN
55311
Approval to add a specification for acceptable pyrogen level to the hypotube component.
P030030/S001
2/9/05
180-Day
Tegress™ Urethral Implant C.R. Bard, Inc.
Covington, GA
30014
Approval for modification of the labeling to reflect a new device trade name. The device, as modified, will be marketed under the trade name Tegress™ Urethral Implant and is indicated for transurethral injection in the treatment of adult women diagnosed with stress urinary incontinence (SUI) due to intrinsic sphincter deficiency (ISD).
P040002/S001
2/15/05
180-Day
Endologix PowerLink® System Endologix, Inc.
Irvine, CA
92618
Approval for the post-approval study protocol.

30-Day Notices (135 Day Supplement was not required)

P860057/S026
2/28/05

Carpentier-Edwards® PERIMOUNT® Pericardial Bioprosthesis, Models 2700, 2700TFX, 2800, 2800TFX, 3000, 3000TFX, 6900P (PERIMOUNT Plus™), and 6900 PTFX

Edwards Lifesciences LLC
Irvine, CA
92614

Addition of an additional semi-automatic torque machine and associated tooling.

P870056/S019
2/28/05

Carpentier-Edwards® Bioprosthesis, Model 2625, 6625 and Valved Conduit Model 4300

Edwards Lifesciences LLC
Irvine, CA
92614

Addition of an additional semi-automatic torque machine and associated tooling.

P870077/S017
2/28/05

Carpentier-Edwards® Duraflex® Low Pressure Bioprosthesis, Models 6625LP and 6625-ESR-LP

Edwards Lifesciences LLC
Irvine, CA
92614

Addition of an additional semi-automatic torque machine and associated tooling.

P950029/S023
2/28/05

Rate-Responsive Pacemakers Implantable Cardioverter Defibrillators

ELA Medical, Inc.
Plymouth, MN
55441

Change in sterilization process parameters.

P980037/S012
2/4/05

AngioJet® Rheolytic Thrombectomy Catheter System

Possis Medical, Inc.
Minneapolis, MN
55433

Change for the supply line nut of the AngioJet Pump Set.

P980049/S018
2/28/05

Rate-Responsive Pacemakers Implantable Cardioverter Defibrillators

ELA Medical, Inc.
Plymouth, MN
55441

Change in sterilization process parameters.

P000007/S006
2/28/05

Edwards Prima Plus Stentless Bioprosthesis 2500P

Edwards Lifesciences LLC
Irvine, CA
92614

Addition of an additional semi-automatic torque machine and associated tooling.

P000021/S005
2/11/05

Dimension® FPSA Flex® Reagent Cartridge

Dade Behring, Inc.
Newark, DE
19714

Change to decrease the quantity of rejected product.

P000025/S018
2/28/05

COMBI 40+/PULSAR Cochlear Implant System

Med-EL Corp.
Durham, NC
27713

New silicone supplier.

P010041/S006
2/28/05

Carpentier-Supraannular (S.A.V.®) Bioprosthesis Model 2650

Edwards Lifesciences LLC
Irvine, CA
92614

Addition of an additional semi-automatic torque machine and associated tooling.

P020027/S002
2/11/05

Dimension® FPSA Flex® Reagent Cartridge

Dade Behring, Inc.
Newark, DE
19714

Change to decrease the quantity of rejected product.

Summary of PMA Originals & Supplements Approved

Originals: 0
Supplements: 45

Summary of PMA Originals Under Review

Total Under Review: 82
Total Active: 41
Total On Hold: 41
Number Greater Than 180 Days: 3

Summary of PMA Supplements Under Review

Total Under Review: 261
Total Active: 150
Total On Hold: 111
Number Greater Than 180 Days: 7

Summary of All PMA Submissions Received

Originals: 3
Supplements: 53

Summary of PMA Supplement PMA Approval/Denial Decision Times

Number of Approvals: 45
Number of Denials: 0
Average Days Fr Receipt to Decision (Total Time): 86.1
FDA Time: 61.4 Days MFR Time: 24.7 Days

Updated March 11, 2005

horizonal rule

CDRH Home Page | CDRH A-Z Index | Contact CDRH | Accessibility | Disclaimer
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | HHS Home Page

Center for Devices and Radiological Health / CDRH